Veritone Declares Q3 2025 Financials Unreliable, Discloses New Material Weakness in Revenue Recognition
VERI sits 85% above its 52-week low of $1.22.
Summary
Veritone, Inc. announced that its Q3 2025 financial statements are unreliable due to accounting errors, including a significant revenue overstatement, and disclosed a new material weakness in internal controls over revenue recognition.
Key Events · Legal and Risk Events · VERI
-
Non-Reliance on Q3 2025 Financials
Management and the Audit Committee determined that the unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2025, should no longer be relied upon due to multiple accounting errors.
-
Significant Revenue Overstatement
Errors included an approximate $2.2 million overstatement of revenue (8% of previously reported Q3 2025 revenue) related to the valuation of consideration from a non-monetary asset exchange.
-
New Material Weakness Identified
The company identified a new material weakness in internal control over financial reporting concerning revenue recognition for non-routine transactions, aggregating with previously disclosed weaknesses. This led to a conclusion that disclosure controls were ineffective as of December 31, 2025.
-
Intends to Restate Financials
Veritone plans to restate its Q3 2025 financial statements in an amended Form 10-Q and will also correct immaterial errors from Q2 2025 within this filing.
Analysis · VERI · Technology
This 8-K filing is highly significant as Veritone, Inc. has declared its previously issued unaudited condensed consolidated financial statements for Q3 2025 (and Q2 2025 for immaterial errors) can no longer be relied upon. The company identified multiple errors, including a $2.2 million overstatement of revenue for Q3 2025 due to improper valuation of a non-monetary asset exchange, and other revenue recognition issues. Critically, management also identified a new material weakness in internal control over financial reporting related to non-routine revenue transactions, which compounds previously disclosed weaknesses. This indicates systemic accounting control deficiencies and will likely lead to a restatement in an amended 10-Q. Investors should be concerned about the reliability of financial reporting and the potential for further issues.
At the time of this filing, VERI was trading at $2.26 on NASDAQ in the Technology sector, with a market capitalization of approximately $209.3M. The 52-week trading range was $1.22 to $9.42. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.